Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Cell Biol Int ; 38(4): 526-30, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24353036

RESUMEN

(+)-Catechin is a type of catechin present in large amounts in açaí fruits and cocoa seeds. Besides its antioxidant and anti-inflammatory activities, little is known about its effects in the liver, especially during hepatic fibrosis. We report here the effects of (+)-catechin on hepatic stellate cells. (+)-Catechin induced quiescent phenotype in GRX cells, along with an increase in lipid droplets. Proliferator-activated receptor γ mRNA expression was upregulated, whereas type I collagen mRNA expression was downregulated. Pro-inflammatory cytokines were not influenced by (+)-catechin, whereas the levels of interleukin 10 were significantly increased. The data provide evidence that (+)-catechin can reduce hepatic stellate cell activation.


Asunto(s)
Catequina/farmacología , Células Estrelladas Hepáticas/efectos de los fármacos , Animales , Línea Celular , Colágeno Tipo I/genética , Colágeno Tipo I/metabolismo , Citocinas/metabolismo , Regulación hacia Abajo/efectos de los fármacos , Células Estrelladas Hepáticas/citología , Interleucina-10/metabolismo , Lípidos/biosíntesis , Ratones , PPAR gamma/genética , PPAR gamma/metabolismo , ARN Mensajero/metabolismo , Estereoisomerismo , Regulación hacia Arriba/efectos de los fármacos
2.
Inflammation ; 34(6): 539-50, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20882329

RESUMEN

Sepsis is a syndrome caused by uncontrolled systemic inflammatory response of the individual, which represents a serious epidemiological problem worldwide. The aim of this study was to investigate the effect of N-acetylcysteine (NAC) and fructose-1,6-bisphosphate (FBP) in the treatment of experimental sepsis. We used rats that were divided into five experimental groups: normal control (not induced), septic control (induced using a capsule with non sterile fecal content and Escherichia coli), treated with FBP (500 mg/kg i.p.), treated with NAC (150 mg/kg i.p.), and treated with the combination of FBP with NAC. In the group treated with NAC, 16.68% of the mice survived, the FBP reduced the mortality of mice during the acute stage of the disease and increased the animals' survival time in 33.34%, and the combination of drugs had no effect. Our results show that NAC prevented the mortality of animals after septic induction. These data confirm the validity of the use of NAC in the treatment of sepsis. Our data also show that the synergistic action with FBP does not improve the picture.


Asunto(s)
Acetilcisteína/uso terapéutico , Fructosa-Bifosfatasa/uso terapéutico , Sepsis/tratamiento farmacológico , Acetilcisteína/farmacología , Animales , Sinergismo Farmacológico , Quimioterapia Combinada , Fructosa-Bifosfatasa/farmacología , Ratas , Sepsis/mortalidad , Tasa de Supervivencia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA